# Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome

> **NCT07635394** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 258 (estimated)

## Conditions studied

- Irritable Bowel Syndrome (IBS)

## Interventions

- **DRUG:** The pregabalin group
- **DRUG:** Routine Treatment

## Key facts

- **NCT ID:** NCT07635394
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-07
- **Primary completion:** 2026-04-08
- **Final completion:** 2029-03-31
- **Target enrollment:** 258 (ESTIMATED)
- **Last updated:** 2026-06-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635394, "Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07635394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*